Showing 1 - 6 results of 6 for search 'Monica Bocchia', query time: 0.01s Refine Results
  1. 1
    Single agent lenalidomide activity in multiple myeloma relapse evidenced uniquely by CT/PET

    Single agent lenalidomide activity in multiple myeloma relapse evidenced uniquely by CT/PET by Alessandro Gozzetti, Vania Rossi, Alfonso Cerase, Giulia Papini, Marzia Defina, Monica Bocchia

    Published 2014-08-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Single agent lenalidomide activity in multiple myeloma relapse evidenced uniquely by CT/PET

    Single agent lenalidomide activity in multiple myeloma relapse evidenced uniquely by CT/PET by Alessandro Gozzetti, Vania Rossi, Alfonso Cerase, Giulia Papini, Marzia Defina, Monica Bocchia

    Published 2012-01-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Single agent lenalidomide activity in multiple myeloma relapse evidenced uniquely by CT/PET

    Single agent lenalidomide activity in multiple myeloma relapse evidenced uniquely by CT/PET by Alessandro Gozzetti, Vania Rossi, Alfonso Cerase, Giulia Papini, Marzia Defina, Monica Bocchia

    Published 2012-06-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Allogeneic Hematopoietic Stem Cell Transplantation Despite Severe <i>Fusarium solani</i> Infection in a Lung Transplanted Patient—A Case Report

    Allogeneic Hematopoietic Stem Cell Transplantation Despite Severe <i>Fusarium solani</i> Infection in a Lung Transplanted Patient—A Case Report by Monica Tozzi, Adele Santoni, Marta Franceschini, Margherita Malchiodi, Irene Bernareggi, Beatrice Esposito Vangone, Corrado Zuanelli Brambilla, Elisabetta Zappone, Mariapia Lenoci, Francesca Toraldo, Valeria Del Re, Alice Pietrini, Elena Marchini, Antonella Fossi, David Bennett, Elena Bargagli, Giuseppe Marotta, Alessandro Bucalossi, Monica Bocchia

    Published 2025-03-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Longitudinal immunogenicity cohort study of SARS-CoV-2 mRNA vaccines across individuals with different immunocompromising conditions: heterogeneity in the immune response and crucial role of Omicron-adapted booster dosesResearch in context

    Longitudinal immunogenicity cohort study of SARS-CoV-2 mRNA vaccines across individuals with different immunocompromising conditions: heterogeneity in the immune response and cruci... by Annalisa Ciabattini, Elena Pettini, Fabio Fiorino, Jacopo Polvere, Simone Lucchesi, Chiara Coppola, Simone Costagli, Gabiria Pastore, Anna Sicuranza, Monica Tozzi, Arianna Lippi, Francesca Panza, Monica Bocchia, Alessandro Bucalossi, Guido Garosi, David Bennett, Sonia Bernazzali, Massimiliano Fabbiani, Francesca Montagnani, Donata Medaglini

    Published 2025-03-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Safety run-in and part 1 of GIMEMA AML1718: venetoclax combined with FLAI as induction treatment in non–low-risk AML

    Safety run-in and part 1 of GIMEMA AML1718: venetoclax combined with FLAI as induction treatment in non–low-risk AML by Giovanni Marconi, Alfonso Piciocchi, Ernesta Audisio, Cristina Papayannidis, Marco Cerrano, Clara Minotti, Francesca Paoloni, Fabio Guolo, Monica Bocchia, Michela Rondoni, Albana Lico, Matteo G. Carrabba, Matteo Giovanni Della Porta, Marco Frigeni, Luisa Giaccone, Germana Beltrami, Chiara Cattaneo, Maria Chiara Di Chio, Bianca Serio, Enrico Crea, Roberto Freilone, Saveria Capria, Antonio Curti, Paola Minetto, Edoardo la Sala, Jacopo Nanni, Beatrice Anna Zannetti, Giorgia Simonetti, Maria Teresa Bochicchio, Giuseppe Saglio, Roberto M. Lemoli, Adriano Venditti, Marco Vignetti, Paola Fazi, Giovanni Martinelli

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: